Volume 9, Issue 2 (Vol.9, No.2, 2020 2020)                   aumj 2020, 9(2): 165-170 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sangani A, Azizi L S, Abolghasemzadeh M, Jangi P. The Effect of Growth Hormone Based on ELISA Method on the Treatment of Schizophrenic Patients. aumj 2020; 9 (2) :165-170
URL: http://aums.abzums.ac.ir/article-1-1086-en.html
1- Department of Psychology, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran , sangany.psycho@gmail.com
2- Department of Nursing, Gorgan Branch, Islamic Azad University, Gorgan, Iran
3- Department of Psychology, Semnan Branch, Islamic Azad University, Semnan, Iran
4- Department of Psychiatry, Ahvaz University of Medical Sciences, Ahwaz, Iran
Abstract:   (2724 Views)
Background: By studying the types of hormones, the role of genetic and hormonal and chemical agents in schizophrenia can be found. The aim of this study was to determine the effectiveness of Growth Hormone based on ELISA method on the Treatment of Schizophrenic Patients.
Methods: This study was a semi-experimental study with pretest-posttest with control group. The study population consisted of all schizophrenic patients admitted to Bostan psychiatric hospital in Ahvaz. A sample of 60 patients was selected using the available method and divided into two experimental and control groups.
Results: In this study, there was significant difference between the level of growth hormone in pre and post-treatment patients. Therefore, more studies are recommended on this hormone (P<0/001).
Conclusion: According to research findings, it can be concluded that changes in growth hormone in the treatment of schizophrenic patients have effect on their treatment.
Full-Text [PDF 117 kb]   (1221 Downloads)    
Type of Study: Research | Subject: Special
Received: 2020/04/21 | Accepted: 2020/04/21 | Published: 2020/04/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Alborz University Medical Journal

Designed & Developed by : Yektaweb